Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2022
Biognosys launches expanded proteomics platform suite
Biognosys announced the launch of an expanded suite of proteomics platforms—TrueDiscovery, TrueTarget, and TrueSignature—for pharmaceutical and diagnostics customers across the R&D pipeline.
2019
Indivumed and Biognosys announce strategic partnership
Indivumed announced a partnership with Biognosys to add proteome-level data from thousands of samples to the IndivuType multi-omics cancer database using Biognosys' proteomics technology.